Short Term Effects of Leptin Withdrawal or Initiation in Lipodystrophy Independent of Energy Intake

Trial Profile

Short Term Effects of Leptin Withdrawal or Initiation in Lipodystrophy Independent of Energy Intake

Recruiting
Phase of Trial: Phase II

Latest Information Update: 19 May 2017

At a glance

  • Drugs Metreleptin (Primary)
  • Indications Lipodystrophy
  • Focus Pharmacodynamics
  • Most Recent Events

    • 03 Nov 2016 Planned primary completion date changed from 1 Oct 2015 to 1 Oct 2017.
    • 09 Jun 2015 Planned number of patients changed from 20 to 40 as reported by ClinicalTrials.gov
    • 09 Jun 2015 Planned End Date changed from 1 Oct 2015 to 1 Dec 2017 as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top